Isogenica will be attending The One Nucleus flagship conference, On Helix.
On Helix provides an excellent opportunity to bring the network together to present and discuss the main innovation and
technology trends in healthcare research and development.
Following 2020 and the way the life science community combined
resources, ingenuity and hard work to deliver prophylactic and
therapeutic tools against the pandemic, many lessons can be
learnt on better translating science and developing therapeutics
and healthcare technologies.
Throughout the one and a half days of ON Helix, our Director of Business Development, Dr David Mead, and Associate Director of Marketing, Dr Mandeep Sehmi, will observe talks that will address the latest innovations and technologies in Medicines.